Skip to main navigation menu Skip to main content Skip to site footer

RETAINED PRODUCTS OF CONCEPTION

Manejo Conservador de Retención de Productos de la Concepción con Anticonceptivos Orales Combinados. Presentación de Caso CONSERVATIVE MANAGEMENT WITH COMBINED ORAL CONTRACEPTIVES. CASE DEPICTION





Section
Artículos de Reportes de Caso

How to Cite
Ruiz Hoyos, B. M. . (2021). RETAINED PRODUCTS OF CONCEPTION: CONSERVATIVE MANAGEMENT WITH COMBINED ORAL CONTRACEPTIVES. CASE DEPICTION. Archivos De Medicina (Manizales), 21(1), 215-224. https://doi.org/10.30554/archmed.21.1.3530.2021
Download Citation

Dimensions
PlumX

How to Cite

Ruiz Hoyos, B. M. . (2021). RETAINED PRODUCTS OF CONCEPTION: CONSERVATIVE MANAGEMENT WITH COMBINED ORAL CONTRACEPTIVES. CASE DEPICTION. Archivos De Medicina (Manizales), 21(1), 215-224. https://doi.org/10.30554/archmed.21.1.3530.2021

Download Citation

Bayron Manuel Ruiz Hoyos

Bayron Manuel Ruiz Hoyos,

Medico Ginecoobstetra, Magister en Educación, Profesor Asociado, Universidad del Quindío. Armenia, Colombia.


SUMMARY

Objective: to show the case of a patient with retained products of conception (RPC) after a medical abortion, succesfully treated with combined oral contraceptives (COC), and review the literature. Clinical Case: A 37-year-old woman, with scant bleeding and mild pelvic pain, who had a misoprostol induced medical abortion three days before, at admission she had no signs of infection and a 19 mm mixed endometrial finding. In clinical and ultrasound monitoring during six weeks, mixed endometrium persists, with slow decrease in human chorionic gonadotrophin (HCG), and RPC is suspected, so that a COC cycle is supplied and when finished she has complete expulsion of retained tissue. Two months later hysteroscopy is normal. Discussion: RPC occurs after childbirth or abortion, diagnostic criteria are: persistent bleeding, ultrasound findings and HCG measurement; the differential diagnosis includes gestational trophoblastic disease and uterine arteriovenous malformations. Conservative management is feasible with low rates of infection or surgical procedures, however, given prolonged evolution, the presence of signs of infection or significant bleeding, surgical evacuation is mandatory, traditionally with dilation and curettage, and more recently, hysteroscopic resection. In our case, the patient took a COC cycle and at the end she expeled the retained remains. Conclusions: the conservative management of CPR with COC arises as an option in selected cases, controlled studies are necessary to define its usefulness.

Keywords: misoprostol, incomplete abortion, combined oral contraceptives.


Article visits 2316 | PDF visits 43


Downloads

Download data is not yet available.
  1. Debby A, Malinger E, Harow E, Golan A, Glezerman M. Transvaginal ultrasound after first-trimester uterine evacuation reduces the incidence of retained products of conception. Ultrasound Obstet Gynecol. 2006; 27(1):61-64. DOI: 10.1002/uog.2654
  2. , Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception, Int J Gynecol Obstet. 2014; 127(1):86-89. http://dx.doi.org/10.1016/j.ijgo.2014.05.003
  3. Hooker AB, Aydin H, Brôlmann HA, Huirne JA. Long term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertility and Sterility. 2016; 105(1):156-164. https://doi.org/10.1016/j.fertnstert.2015.09.021
  4. Klement AH, Frederic M, Bentov Y, Chang P, Nayot D, Haas J, et al. Oral contraceptive pills as an option for non-surgic al management of retained products of conception-a preliminary study. Gynecol Endocrinol. 2018; 34(7):609-611. DOI: 10.1080/09513590.2018.1427714
  5. Jimenez JS, Gonzalez C, Alvarez C, Muñoz L, Perez C, Muñoz J. Conservative management of retained trophoblastic tissue and placental polyp with diagnostic ambulatory hysteroscopy. Eur J Obstet Gynecol Reprod Biol. 2009; 145(1): 89–92. https://doi.org/10.1016/j.ejogrb.2009.04.001
  6. Harish KM, Shwetha N, Dipankar D. Comparative análisis of hysteroscopy versus suction evacuation in the management of retained products of conception. Int J Reprod Contracept Obstet Gynecol. 2018; 7(6):2155-2159. http://dx.doi.org/10.18203/2320-1770.ijrcog20182009
  7. Sellmyer MA, Desser TS, Maturen KE, Jeffrey RB, Kamaya A. Physiologic, Histologic, and Imaging Features of Retained Products of Conception. Radiographics. 2013; 33(3):781-796. DOI: 10.1148/rg.333125177
  8. Casikar I, Bignardi T, Riemke J, Alhamdan D, Condous G. Expectant management of spontaneous first-trimester miscarriage: pospective validation of the “2 weeks rule”. Ultrasound Obstet Gynecol. 2010; 35(2): 223–227. DOI: 10.1002/uog.7486
  9. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ. 2006; 332(7552):1235-1240. DOI: 10.1136/bmj.38828.593125.55
  10. Barnhart K, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of Serum Human Chorionic Gonadotropin and Spontaneous Complete Abortion: defining the Normal Curve. Obstet Gynecol. 2004; 104(5) 975-981. DOI: 10.1097/01.AOG.0000142712.80407.fd
  11. Pocius KD, Maurer R, Fortin J, Goldberg AB, Bartz D. Early serum human chorionic gonadotropin (hCG) trends after medication abortion. Contraception. 2015; 91(6): 503–506. DOI: 10.1016/j.contraception.2015.03.004
  12. Pourali L, Ayati S, Layegh P, Vatanchi A, Rastin Z, Shourvi A. Persistent low levels of Beta-hCG: a pitfall in diagnosis of Retained products of Conception. Acta Med Iran. 2018; 56(7):478-481.
  13. Tohma YA, Dilbaz B, Evliyaoğlu O, Çoşkun B, Çolak E, Dilbaz S. Is ultrasonographic evaluation essential for diagnosis of retained products of conception after surgical abortion? J Obstet Gynaecol Res. 2016; 42(5):489-495. https://doi.org/10.1111/jog.12944
  14. Reeves MF, Fox MC, Lohr PA, M. D. Creinin MD. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet Gynecol. 2009; 34(1):104–109. DOI: 10.1002/uog.6404
  15. Sawyer E, Ofuasia E, Ofili-Yebovi D, Helmy S, Gonzalez J, Jurkovic D. The value of measuring endometrial thickness and volumen on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound Obstet Gynecol. 2007; 29(2):205–209. DOI: 10.1002/uog.3914
  16. Chopra N, Kaur M, Kaur-Mohi M. Correlation of ultrasound with histopathology for retained products of conception in medically managed abortions. Int J Reprod Contracept Obstet Gynecol. 2017; 6(8):3372-3375. http://dx.doi.org/10.18203/2320-1770.ijrcog20173373
  17. Hameed BH. Incomplete miscarriage, expectant versus medical management and the use of Doppler sonography for patient selection. Iraqi J Comm Med. 2016; 2:10-15.
  18. Van den Bosch T, Van Schoubroeck D, Timmerman D. Maximum Peak Systolic Velocity and Management of Highly Vascularized Retained Products of Conception. J Ultrasound Med. 2015; 34(9):1577–1582. DOI: 10.7863/ultra.15.14.10050
  19. Betel C, Atri M, Arenson AM, Khalifa M, Osborne R, Tomlinson G. Sonographic Diagnosis of Gestational Trophoblastic Disease and Comparison With Retained Products of Conception. J Ultrasound Med. 2006; 25(8):985–993. DOI: 10.7863/jum.2006.25.8.985
  20. Jain K, Fogata M. Retained Products of Conception Mimicking a Large Endometrial AVM: Complete Resolution Following Spontaneous Abortion. J Ultrasound Med. 2007; 35(1):42-47. DOI: 10.1002/jcu.20250
  21. Vilos AG, Vilos GA, Hollett-Caines J, Rajakumar C, Garvin G, Kozack R. Uterine artery embolization for uterine arteriovenous malformation in five women desiring fertility: pregnancy outcomes. Hum Reprod. 2015; 30(7):1599–1605. DOI: 10.1093/humrep/dev097
  22. Hashim H, Nawawi O. Uterine arteriovenous malformation. Malays J Med Sci. 2013; 20(2):76-80.
  23. Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017; 1:1-2. DOI: 10.1002/14651858.CD007223.pub4
  24. Lemmers M, Verschoor MA, Regenrink KO, Naaktgeboren C, Opmeer BC, Bossuyt PM, et al. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial. Hum Reprod. 2016; 31(11):2421-2427. DOI:10.1093/humrep/dew221
  25. Kaviani M, Tehrani TA, Azima S, Abdali K, Asadi N. Comparison of the Effects of Simultaneous Use of Methylergonovine and Combined Low-dose (LD) Contraceptive Pills on Hemorrhage Due to Retained Pregnancy Products after Abortion. Int J Curr Microbiol App Sci. 2016; 5(11):499-507. http://dx.doi.org/10.20546/ijcmas.2016.511.058
  26. Lethaby A, Wise MR, Weterings MA, Bofill-Rodriguez M, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;2:1-3. DOI: 10.1002/14651858.CD000154.pub3
  27. Martin CW, Brown AH, Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception. 1998; 58(2):99-103. DOI: 10.1016/s0010-7824(98)00072-9
  28. Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014; 173:19–22. https://doi.org/10.1016/j.ejogrb.2013.11.020